REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Farmasi Ipoh Garden South Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Farmasi Ipoh Garden South Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Wholesale & retail of pharmaceutical and medical related products, sale of consumables through vending machines, retail sale of rice and all kinds of grains

Headquarters
No. 12-14, Tingkat Taman Ipoh 12, Taman Ipoh Selatan
Ipoh; Perak; Postal Code: 31400

Contact Details: Purchase the Farmasi Ipoh Garden South Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Farmasi Ipoh Garden South Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Farmasi Ipoh Garden South Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Farmasi Ipoh Garden South Sdn. Bhd. report to view the information.
Incorporation Date:
August 01, 2013
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
51%
Purchase this report to view the information.
49%
Subsidiaries
Htm Pharmacy (Simee) Sdn. Bhd.
60%
Htm Pharmacy (Seri Kembangan) Sdn. Bhd.
51%
Company Performance
Financial values in the chart are available after Farmasi Ipoh Garden South Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-1.68%▼
Total operating revenue
-1.68%▼
Operating profit (EBIT)
-77.63%▼
Net Profit (Loss) for the Period
-75.65%▼
Total assets
42.1%▲
Total equity
155.89%▲
Operating Profit Margin (ROS)
-5.81%▼
Net Profit Margin
-4.51%▼
Return on Equity (ROE)
-123.34%▼
Quick Ratio
0.53%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo